Logo image of WGS

GENEDX HOLDINGS CORP (WGS) Stock Fundamental Analysis

NASDAQ:WGS - Nasdaq - US81663L2007 - Common Stock

80.33  +5.97 (+8.03%)

Fundamental Rating

3

WGS gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 108 industry peers in the Health Care Providers & Services industry. The financial health of WGS is average, but there are quite some concerns on its profitability. WGS is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

WGS had negative earnings in the past year.
In the past year WGS has reported a negative cash flow from operations.
In the past 5 years WGS always reported negative net income.
WGS had a negative operating cash flow in each of the past 5 years.
WGS Yearly Net Income VS EBIT VS OCF VS FCFWGS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 -200M -400M -600M

1.2 Ratios

Looking at the Return On Assets, with a value of -20.42%, WGS is doing worse than 79.44% of the companies in the same industry.
WGS's Return On Equity of -40.83% is on the low side compared to the rest of the industry. WGS is outperformed by 70.09% of its industry peers.
Industry RankSector Rank
ROA -20.42%
ROE -40.83%
ROIC N/A
ROA(3y)-66.03%
ROA(5y)-62.01%
ROE(3y)-118.9%
ROE(5y)-1173.25%
ROIC(3y)N/A
ROIC(5y)N/A
WGS Yearly ROA, ROE, ROICWGS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 -1K -2K -3K -4K -5K

1.3 Margins

WGS has a better Gross Margin (59.48%) than 80.37% of its industry peers.
In the last couple of years the Gross Margin of WGS has grown nicely.
WGS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 59.48%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y7.53%
WGS Yearly Profit, Operating, Gross MarginsWGS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 0 -100 -200

More info and screens

5

2. Health

2.1 Basic Checks

WGS does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, WGS has more shares outstanding
Compared to 1 year ago, WGS has a worse debt to assets ratio.
WGS Yearly Shares OutstandingWGS Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M
WGS Yearly Total Debt VS Total AssetsWGS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 100M 200M 300M 400M 500M

2.2 Solvency

An Altman-Z score of 1.86 indicates that WGS is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of WGS (1.86) is comparable to the rest of the industry.
A Debt/Equity ratio of 0.25 indicates that WGS is not too dependend on debt financing.
WGS's Debt to Equity ratio of 0.25 is fine compared to the rest of the industry. WGS outperforms 66.36% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF N/A
Altman-Z 1.86
ROIC/WACCN/A
WACC9.15%
WGS Yearly LT Debt VS Equity VS FCFWGS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 200M -200M

2.3 Liquidity

WGS has a Current Ratio of 2.41. This indicates that WGS is financially healthy and has no problem in meeting its short term obligations.
WGS's Current ratio of 2.41 is amongst the best of the industry. WGS outperforms 80.37% of its industry peers.
A Quick Ratio of 2.27 indicates that WGS has no problem at all paying its short term obligations.
With a decent Quick ratio value of 2.27, WGS is doing good in the industry, outperforming 78.50% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.41
Quick Ratio 2.27
WGS Yearly Current Assets VS Current LiabilitesWGS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 100M 200M 300M 400M

More info and screens

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 91.79% over the past year.
The Revenue has grown by 29.41% in the past year. This is a very strong growth!
WGS shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.73% yearly.
EPS 1Y (TTM)91.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%104.88%
Revenue 1Y (TTM)29.41%
Revenue growth 3Y4.15%
Revenue growth 5Y8.73%
Sales Q2Q%44.22%

3.2 Future

The Earnings Per Share is expected to grow by 30.87% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 26.83% on average over the next years. This is a very strong growth
EPS Next Y94.4%
EPS Next 2Y44.52%
EPS Next 3Y30.87%
EPS Next 5YN/A
Revenue Next Year48.04%
Revenue Next 2Y31.77%
Revenue Next 3Y26.83%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
WGS Yearly Revenue VS EstimatesWGS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M 400M
WGS Yearly EPS VS EstimatesWGS Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -10 -20 -30 -40

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for WGS. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 162.32, which means the current valuation is very expensive for WGS.
61.68% of the companies in the same industry are cheaper than WGS, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 24.44. WGS is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 162.32
WGS Price Earnings VS Forward Price EarningsWGS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50 100 150

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
WGS Per share dataWGS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6 8

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as WGS's earnings are expected to grow with 30.87% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y44.52%
EPS Next 3Y30.87%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for WGS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GENEDX HOLDINGS CORP

NASDAQ:WGS (1/22/2025, 10:32:58 AM)

80.33

+5.97 (+8.03%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)10-29 2024-10-29/bmo
Earnings (Next)02-18 2025-02-18/amc
Inst Owners62.3%
Inst Owner Change-0.03%
Ins Owners2.22%
Ins Owner Change-6.64%
Market Cap2.21B
Analysts76
Price Target82.45 (2.64%)
Short Float %9.25%
Short Ratio3.28
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)92.71%
Min EPS beat(2)67%
Max EPS beat(2)118.42%
EPS beat(4)4
Avg EPS beat(4)61.43%
Min EPS beat(4)9.31%
Max EPS beat(4)118.42%
EPS beat(8)5
Avg EPS beat(8)24.04%
EPS beat(12)8
Avg EPS beat(12)18.04%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)17.42%
Min Revenue beat(2)17.12%
Max Revenue beat(2)17.71%
Revenue beat(4)4
Avg Revenue beat(4)14.93%
Min Revenue beat(4)2.56%
Max Revenue beat(4)22.31%
Revenue beat(8)7
Avg Revenue beat(8)7.45%
Revenue beat(12)10
Avg Revenue beat(12)3.65%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)97.96%
EPS NQ rev (1m)0%
EPS NQ rev (3m)152.01%
EPS NY rev (1m)0%
EPS NY rev (3m)60.26%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)30.5%
Revenue NY rev (1m)0%
Revenue NY rev (3m)9.42%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 162.32
P/S 8.26
P/FCF N/A
P/OCF N/A
P/B 10.79
P/tB 52.05
EV/EBITDA N/A
EPS(TTM)-1.08
EYN/A
EPS(NY)0.49
Fwd EY0.62%
FCF(TTM)-2.18
FCFYN/A
OCF(TTM)-2.01
OCFYN/A
SpS9.73
BVpS7.44
TBVpS1.54
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -20.42%
ROE -40.83%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 59.48%
FCFM N/A
ROA(3y)-66.03%
ROA(5y)-62.01%
ROE(3y)-118.9%
ROE(5y)-1173.25%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y7.53%
F-Score4
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 21.4%
Cap/Sales 1.8%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.41
Quick Ratio 2.27
Altman-Z 1.86
F-Score4
WACC9.15%
ROIC/WACCN/A
Cap/Depr(3y)45.47%
Cap/Depr(5y)130.03%
Cap/Sales(3y)6.24%
Cap/Sales(5y)8.89%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)91.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%104.88%
EPS Next Y94.4%
EPS Next 2Y44.52%
EPS Next 3Y30.87%
EPS Next 5YN/A
Revenue 1Y (TTM)29.41%
Revenue growth 3Y4.15%
Revenue growth 5Y8.73%
Sales Q2Q%44.22%
Revenue Next Year48.04%
Revenue Next 2Y31.77%
Revenue Next 3Y26.83%
Revenue Next 5YN/A
EBIT growth 1Y87.72%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year89.45%
EBIT Next 3Y34.36%
EBIT Next 5YN/A
FCF growth 1Y81.58%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y82%
OCF growth 3YN/A
OCF growth 5YN/A